Oregon Public Employees Retirement Fund Has Increased Its F5 Networks (FFIV) Position; Shorts at Eiger Biopharmaceuticals (EIGR) Raised By 14.33%

September 4, 2017 - By Linda Rogers

Eiger Biopharmaceuticals Incorporated (NASDAQ:EIGR) had an increase of 14.33% in short interest. EIGR’s SI was 107,700 shares in September as released by FINRA. Its up 14.33% from 94,200 shares previously. With 93,600 avg volume, 1 days are for Eiger Biopharmaceuticals Incorporated (NASDAQ:EIGR)’s short sellers to cover EIGR’s short positions. The SI to Eiger Biopharmaceuticals Incorporated’s float is 2.75%. The stock increased 3.78% or $0.35 on September 1, reaching $9.6. About 93,968 shares traded or 69.63% up from the average. Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) has declined 64.64% since September 4, 2016 and is downtrending. It has underperformed by 81.34% the S&P500.

Oregon Public Employees Retirement Fund increased F5 Networks Inc (FFIV) stake by 83.85% reported in 2016Q4 SEC filing. Oregon Public Employees Retirement Fund acquired 13,862 shares as F5 Networks Inc (FFIV)’s stock declined 11.30%. The Oregon Public Employees Retirement Fund holds 30,394 shares with $4.40M value, up from 16,532 last quarter. F5 Networks Inc now has $7.53 billion valuation. The stock decreased 0.68% or $0.81 on September 1, reaching $118.57. About 379,190 shares traded. F5 Networks, Inc. (NASDAQ:FFIV) has risen 21.28% since September 4, 2016 and is uptrending. It has outperformed by 4.58% the S&P500.

Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, is a clinical-stage biopharmaceutical company. The company has market cap of $80.32 million. The Firm is focused on the development and commercialization of products for the treatment of orphan diseases. It currently has negative earnings. The Company’s pipeline includes Sarasar for hepatitis delta virus (HDV), exendin (9-39) for severe hypoglycemia, and Bestatin (ubenimex) for pulmonary arterial hypertension (PAH) and lymphedema.

Investors sentiment increased to 0.99 in Q4 2016. Its up 0.05, from 0.94 in 2016Q3. It improved, as 41 investors sold FFIV shares while 197 reduced holdings. 71 funds opened positions while 151 raised stakes. 60.27 million shares or 2.18% more from 58.99 million shares in 2016Q3 were reported. Meiji Yasuda Asset Mngmt reported 5,220 shares. Advsr Preferred Limited Liability Co holds 0.01% in F5 Networks, Inc. (NASDAQ:FFIV) or 185 shares. Coatue Ltd invested 1.41% of its portfolio in F5 Networks, Inc. (NASDAQ:FFIV). Huntington Commercial Bank holds 1,010 shares. Pictet Asset Mgmt Ltd invested 0.02% in F5 Networks, Inc. (NASDAQ:FFIV). Raymond James Finance Service Advsr reported 0% stake. Montag Caldwell Limited Liability holds 3,936 shares or 0.01% of its portfolio. Dean Invest Assocs Ltd Liability Corporation reported 0.83% of its portfolio in F5 Networks, Inc. (NASDAQ:FFIV). Putnam Limited Liability Co owns 0% invested in F5 Networks, Inc. (NASDAQ:FFIV) for 1,392 shares. Kornitzer Capital Ks invested in 0.31% or 115,500 shares. Quantum Capital Management invested in 29,694 shares. Fjarde Ap reported 14,426 shares. Manufacturers Life The reported 72,885 shares. Cookson Peirce Company reported 2,740 shares. Conning stated it has 0.01% in F5 Networks, Inc. (NASDAQ:FFIV).

Since May 1, 2017, it had 0 insider purchases, and 6 insider sales for $3.54 million activity. DiLullo John D had sold 3,420 shares worth $436,461 on Monday, May 1. Reinland Andrew sold 6,235 shares worth $794,368. $108,248 worth of F5 Networks, Inc. (NASDAQ:FFIV) was sold by Kearny Ryan C. on Monday, May 1. MCADAM JOHN sold $1.30M worth of stock or 10,000 shares. Rogers Scot Frazier sold $306,949 worth of F5 Networks, Inc. (NASDAQ:FFIV) on Monday, May 1. $593,442 worth of stock was sold by EAMES EDWARD JULIAN on Monday, May 1.

Oregon Public Employees Retirement Fund decreased Chevron Corp (NYSE:CVX) stake by 26,126 shares to 482,979 valued at $56.85 million in 2016Q4. It also reduced Citigroup Inc (NYSE:C) stake by 44,397 shares and now owns 670,531 shares. Goldman Sachs Group Inc (NYSE:GS) was reduced too.

Among 33 analysts covering F5 Networks Inc. (NASDAQ:FFIV), 6 have Buy rating, 1 Sell and 26 Hold. Therefore 18% are positive. F5 Networks Inc. had 80 analyst reports since July 24, 2015 according to SRatingsIntel. Pacific Crest maintained F5 Networks, Inc. (NASDAQ:FFIV) on Wednesday, January 13 with “Overweight” rating. Piper Jaffray upgraded the shares of FFIV in report on Thursday, October 27 to “Overweight” rating. As per Thursday, April 21, the company rating was maintained by Robert W. Baird. Jefferies maintained the stock with “Hold” rating in Thursday, August 31 report. The stock has “Hold” rating by Deutsche Bank on Tuesday, January 12. The stock has “Equalweight” rating by Barclays Capital on Wednesday, October 14. The rating was initiated by Drexel Hamilton on Friday, October 9 with “Buy”. The firm has “Sector Weight” rating by Pacific Crest given on Tuesday, May 17. The rating was downgraded by Needham to “Hold” on Thursday, October 29. Drexel Hamilton maintained the stock with “Buy” rating in Friday, July 21 report.